The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: The LARCID trial.
Paulo Marcelo Hoff
Research Funding - Novartis
Daniel Fernandes Saragiotto
No relevant relationships to disclose
Carlos H. Barrios
No relevant relationships to disclose
Auro Del Giglio
No relevant relationships to disclose
Anelisa Kruschewsky Coutinho
No relevant relationships to disclose
Aline C Andrade
No relevant relationships to disclose
Carolina Dutra
No relevant relationships to disclose
Nora Forones
No relevant relationships to disclose
Mariangela Correa
No relevant relationships to disclose
Maria Socorro Portella
Employment or Leadership Position - Novartis
Vanessa Q. Passos
Employment or Leadership Position - Novartis
Renata N Chinen
Employment or Leadership Position - Novartis
Brigitte van Eyll
No relevant relationships to disclose